Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 205

    Aurobindo to acquire under development product, related assets from Advent for Rs 90 crore

    Aurobindo to acquire under development product, related assets from Advent for Rs 90 crore

    Medical Dialogues Bureau14 Nov 2018 2:55 PM IST
    New Delhi: Drug firm Aurobindo Pharma has recently stated that its arm in the USA has signed a pact to acquire an under-development product and...
    Sun Pharma Q2 consolidated net loss at Rs 219 crore

    Sun Pharma Q2 consolidated net loss at Rs 219 crore

    Medical Dialogues Bureau14 Nov 2018 12:00 PM IST
    New Delhi: Drug giant Sun Pharmaceutical Industries (Sun Pharma) has reported a consolidated net loss of Rs 218.82 crore for the July-September...
    Roches Tecentriq gets instant FDA review in tough-to-treat breast cancer

    Roche's Tecentriq gets instant FDA review in tough-to-treat breast cancer

    Medical Dialogues Bureau14 Nov 2018 10:00 AM IST
    ZURICH: As the Swiss drugmaker seeks to be the first company to have its immunotherapy win approval in this indication, Roche's Tecentriq medicine...
    Glenmark teams up with South Korean firm SCD for ophthalmic products

    Glenmark teams up with South Korean firm SCD for ophthalmic products

    Medical Dialogues Bureau14 Nov 2018 9:36 AM IST
    New Delhi: To develop, manufacture and market a portfolio of ophthalmic products in the US and Canada, drug major Glenmark Pharmaceuticals has entered...
    Theravance, Mylan win USFDA approval for COPD Drug Yupelri

    Theravance, Mylan win USFDA approval for COPD Drug Yupelri

    Medical Dialogues Bureau14 Nov 2018 9:00 AM IST
    New Delhi: Mylan has recently announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Yupelri...
    Nestle raises stake in food allergy drug developer Aimmune

    Nestle raises stake in food allergy drug developer Aimmune

    Medical Dialogues Bureau13 Nov 2018 3:53 PM IST
    The health science arm of Nestle SA will pay $98 million to raise its stake in Aimmune Therapeutics Inc, the drug developer said, as it prepares to...
    Lupin gets USFDA nod for Asthma drug

    Lupin gets USFDA nod for Asthma drug

    Medical Dialogues Bureau13 Nov 2018 3:53 PM IST
    New Delhi: Drug major Lupin Tuesday said it has received approval from the US health regulator to market Budesonide Inhalation Suspension single-dose...
    Cipla gets USFDA nod for anti-viral eye infection drug for AIDS patients

    Cipla gets USFDA nod for anti-viral eye infection drug for AIDS patients

    Medical Dialogues Bureau13 Nov 2018 3:53 PM IST
    Drug major Cipla Monday said it has received final approval from the US health regulator for Valganciclovir tablets, used in the treatment of viral...
    Zydus Cadila gets USFDA nod for Anti-Fungal Ointment

    Zydus Cadila gets USFDA nod for Anti-Fungal Ointment

    Medical Dialogues Bureau13 Nov 2018 3:43 PM IST
    New Delhi: Zydus Cadila said it has received final approval from the US health regulator to market Nystatin and Triamcinolone Acetonide Ointment, used...
    China mulls USD 720,000 fine for faking vaccine tests after scandal

    China mulls USD 720,000 fine for faking vaccine tests after scandal

    Medical Dialogues Bureau13 Nov 2018 9:42 AM IST
    Beijing: Chinese vaccine manufacturers who falsify test results or break other rules could be fined up to USD 720,000 under a new law proposed after a...
    Takeda sets vote date, aims to close $62 Billion Shire deal Jan. 8

    Takeda sets vote date, aims to close $62 Billion Shire deal Jan. 8

    Medical Dialogues Bureau13 Nov 2018 9:00 AM IST
    LONDON: Japan's Takeda Pharmaceutical will hold an investor vote on its $62 billion acquisition of Shire next month and aims to close the deal on Jan....
    Cipla gets USFDA nod for generic version of Voltran Gel

    Cipla gets USFDA nod for generic version of Voltran Gel

    Medical Dialogues Bureau12 Nov 2018 11:47 AM IST
    New Delhi: Drug major Cipla has received final approval from the United States Food and Drug Administration (USFDA) for, indicated for the relief of...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok